m+Medelevator.RU
← Поиск публикаций
Journal of tropical pediatrics · 2026

Prevalence of multidrug-resistant organisms colonizing neonates at a tertiary hospital in Johannesburg, South Africa.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mntla Nonkululeko, Chibabhai Vindana, Nana Trusha

Аннотация

Neonatal mortality remains a global health challenge, particularly in sub-Saharan Africa, where infections often caused by multidrug-resistant (MDR) organisms are a leading cause of death. This study aimed to assess the prevalence of MDR ESKAPE pathogens and Candida auris colonization among hospitalized neonates in a non-outbreak setting, identify associated risk factors, and characterize antimicrobial resistance patterns. A cross-sectional sub-study was conducted at a tertiary hospital in South Africa between November and December 2020. A total of 258 rectal and skin swabs were collected from 86 neonates and cultured for ESKAPE organisms and C. auris. Isolated MDR organisms underwent further characterization. Of the 135 ESKAPE + C. auris isolates identified, 70.4% (95/135) were MDR. Colonization with ESBL-producing Klebsiella pneumoniae was most common (65%, 56/86), followed by XDR Acinetobacter baumannii. NDM-producing A. baumannii (5.8%) was more frequently detected than carbapenemase-producing Enterobacterales (3.9%). A prolonged hospital stay (median 14 days, P < .001) was significantly associated with MDR colonization. Rectal and skin swabs provided comparable yields for Gram-negative MDR organisms. The high prevalence of MDR ESKAPE + C. auris colonization highlights the value of routine, non-invasive screening for surveillance in neonatal units. Enhanced infection control strategies and improved surveillance systems incorporating colonization swabs and clinical risk profiling are urgently needed.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты